State Street’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
State Street's LTGO Position: Q3 2026 in Review
State Street opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 23,700 shares worth $396K. The stake represents ﹤0.01% of the portfolio and ranks #3722 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- State Street held 23,700 shares of Latigo Biotherapeutics worth $396K as of Q3 2026.
- Latigo Biotherapeutics was a new State Street position in Q3 2026.
- Latigo Biotherapeutics made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3722 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.